Sotac Pharmaceuticals Limited

NSE: SOTAC · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹90.05
Market cap: ₹99.51 Cr
Revenue (annual): ₹101.2 Cr
Net profit (annual): ₹6.29 Cr
P/E (TTM): 15.8×Sector 47.4×
Promoter holding: 72.85%
FII holding: 16.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Financial Results 2 Dividend 2 New Order Win 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

26 May 2026 20:45 IST NSE

Financial Results

Sotac Pharmaceuticals H2 FY26 Results: Net Profit ₹3.3 Cr, Down 45.9% YoY

Sotac Pharmaceuticals Limited reported revenue from operations of ₹60.1 Cr (+27.6% YoY) and net profit of ₹3.3 Cr (-45.9% YoY) for H2 FY26.

Key figure: Net profit ₹3.3 Cr · -45.9% YoY

Open full results → Read the filing ↗

26 May 2026 20:44 IST NSE

Financial Results

Sotac Pharmaceuticals Financial Results

Sotac Pharmaceuticals reported audited FY26 results and proposed a Rs. 0.20 per share dividend. Consolidated annual revenue reached ₹101.24 Crore with a net profit of ₹5.77 Crore.

Value: ₹0.22 Cr

Read the filing ↗